Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)

Ahn-Gook Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15,844	28,991	18,219	13,650	12,768
Short-Term Investments	2,300	5,050	11,050	7,496	6,877
Trading Asset Securities	11,594	1,405	9,173	26,314	30,624
Cash & Short-Term Investments	29,738	35,446	38,442	47,460	50,269
Cash Growth	-16.10%	-7.79%	-19.00%	-5.59%	-36.65%
Accounts Receivable	58,722	62,132	54,917	43,059	33,060
Other Receivables	133.27	461.03	519.21	817.96	1,250
Receivables	59,015	62,753	55,597	44,159	37,737
Inventory	44,672	35,718	26,594	23,891	22,669
Prepaid Expenses	223.64	130.74	75.04	90.25	211.36
Other Current Assets	1,123	1,368	1,302	683.49	545.92
Total Current Assets	134,772	135,416	122,010	116,285	111,432
Property, Plant & Equipment	120,069	73,036	70,771	70,911	70,554
Long-Term Investments	28,043	22,927	23,037	26,872	18,977
Other Intangible Assets	3,901	4,287	4,087	3,874	3,378
Long-Term Deferred Tax Assets	2,086	1,722	2,816	843.94	1,113
Other Long-Term Assets	13,664	1,208	1,193	1,171	1,529
Total Assets	302,535	238,598	223,912	219,956	206,984
Accounts Payable	10,265	15,208	12,643	10,141	9,048
Accrued Expenses	12,060	10,619	8,974	6,141	1,257
Short-Term Debt	27,300	17,300	19,450	19,600	19,900
Current Portion of Long-Term Debt	-	-	8.25	60.93	144.72
Current Portion of Leases	197.36	259.14	336.51	296.49	357.66
Current Income Taxes Payable	3,652	238.13	1,369	383.15	-
Current Unearned Revenue	-	-	0.78	18.55	3.23
Other Current Liabilities	23,585	34,619	18,717	15,572	13,967
Total Current Liabilities	77,059	78,242	61,498	52,212	44,678
Long-Term Debt	50,000	-	-	8.25	69.18
Long-Term Leases	226.52	120.27	210.13	225.69	332.83
Other Long-Term Liabilities	1,483	520.06	402.69	316.44	209.46
Total Liabilities	137,792	86,932	69,241	66,675	57,558
Common Stock	6,521	6,521	6,521	6,521	6,521
Additional Paid-In Capital	15,531	15,531	15,531	15,531	15,547
Retained Earnings	145,070	131,553	133,487	127,754	126,215
Treasury Stock	-4,941	-4,941	-4,941	-4,387	-3,967
Comprehensive Income & Other	3,494	3,422	4,199	8,001	5,065
Total Common Equity	165,676	152,086	154,798	153,421	149,380
Minority Interest	-932.34	-420.65	-126.44	-140.14	45.11
Shareholders' Equity	164,743	151,666	154,671	153,281	149,425
Total Liabilities & Equity	302,535	238,598	223,912	219,956	206,984
Total Debt	77,724	17,679	20,005	20,191	20,804
Net Cash (Debt)	-47,986	17,767	18,437	27,269	29,465
Net Cash Growth	-	-3.63%	-32.39%	-7.45%	-41.52%
Net Cash Per Share	-4221.58	1569.95	1620.25	2380.83	2329.62
Filing Date Shares Outstanding	11.37	11.37	11.37	11.41	11.46
Total Common Shares Outstanding	11.37	11.37	11.31	11.41	11.46
Working Capital	57,713	57,174	60,511	64,072	66,754
Book Value Per Share	14577.25	13381.56	13683.36	13441.11	13035.90
Tangible Book Value	161,774	147,799	150,711	149,547	146,002
Tangible Book Value Per Share	14233.98	13004.33	13322.13	13101.72	12741.09
Land	36,756	19,501	19,501	19,501	19,501
Buildings	77,096	34,393	19,510	34,222	33,855
Machinery	42,522	34,066	29,974	33,184	31,149
Construction In Progress	830.04	24,210	22,712	21,973	21,432

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.